Cite
HARVARD Citation
Wu, X. et al. (n.d.). 79P Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study. Immuno-oncology technology. p. . [Online].